arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

SI-BONE, Inc.

SIBN Health Care Medical/Dental Instruments
$18.50
Today
as of Sep 4, 16:54 ET
Last 30 days +8.50% Jul 27 → Sep 04
$16.82 $17.66 $18.50 $19.35 $20.19 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$18.50
High
$18.75
Low
$18.20
Volume
$389,529
Avg Vol
$577,629
Mkt Cap
$849M
P/E (TTM)
—
Beta
—
52w High
$21.89
52w Low
$11.48
Div Yield
—
Shares Out
$45M

Recent Press Releases & News last 60 days · 7 items

Aug 25 · 16:00 Zacks
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?
Aug 24 · 13:55 Zacks
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade
Aug 11 · 01:29 Motley Fool
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript
▸ Show all 7 press releases & news Free account →

Overview

52-week range
$11
$22
67% of range
Avg surprise (last 3)
+35.0%
Avg reaction (last 2)
-1.8%
50% positive
Latest IV / EM
111%
EM ±17.3% · $20 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.32$-0.26$-0.21$-0.15$-0.09 Actual $-0.32Actual $-0.30Actual $-0.25Actual $-0.27Actual $-0.22Actual $-0.16Actual $-0.15Est $-0.24Actual $-0.14Est $-0.19Actual $-0.11Actual $-0.10Est $-0.17Actual $-0.09 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-7M$10M$26M$42M$59M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.09 — — — — financials
Mon May 11, 2026Mar/2026 $-0.10 $-0.17 +41.2% +33.3% -5.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.11 — — — — financials
Mon Aug 4, 2025Jun/2025 $-0.14 $-0.19 +26.3% — — earnings
Mon May 5, 2025Mar/2025 $-0.15 $-0.24 +37.5% — +1.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.16 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.22 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.27 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.25 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.30 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.32 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$56M$53M—$49M$49M$47M—$40M
Cost of revenue$11M$11M—$10M$10M$10M—$8M
Gross profit$45M$42M—$39M$39M$38M—$32M
Operating income$-5M$-5M—$-5M$-7M$-7M—$-8M
Net income$-4M$-4M—$-5M$-6M$-7M—$-7M
EPS (diluted)$-0.09$-0.10—$-0.11$-0.14$-0.15—$-0.16

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$33M$34M$42M$26M$34M$41M$35M$30M
Inventory$38M$36M$34M$36M$34M$30M$27M$26M
Total current assets$220M$215M$216M$211M$207M$204M$208M$204M
Total assets$249M$243M$239M$234M$231M$227M$230M$227M
Long-term debt$36M$36M$36M$36M$36M$35M$35M$36M
Total liabilities$66M$64M$61M$62M$61M$60M$63M$62M
Total equity$182M$179M$178M$172M$170M$167M$167M$165M

Implied volatility — last 90 days

38%74%110%146%182% Jun 12 — IV 38% · EM ±3.9%Jun 19 — IV 67% · EM ±14.8%Jun 22 — IV 79% · EM ±16.4%Jun 23 — IV 61% · EM ±12.5%Jun 24 — IV 53% · EM ±10.6%Jun 25 — IV 45% · EM ±8.8%Jun 26 — IV 41% · EM ±7.8%Jun 29 — IV 44% · EM ±7.8%Jun 30 — IV 57% · EM ±9.8%Jul 01 — IV 48% · EM ±8.0%Jul 02 — IV 41% · EM ±6.6%Jul 03 — IV 42% · EM ±6.6%Jul 06 — IV 46% · EM ±6.4%Jul 07 — IV 44% · EM ±5.8%Jul 08 — IV 48% · EM ±6.1%Jul 09 — IV 47% · EM ±5.6%Jul 10 — IV 41% · EM ±4.6%Jul 13 — IV 50% · EM ±4.2%Jul 14 — IV 63% · EM ±4.6%Jul 15 — IV 74% · EM ±4.3%Jul 16 — IV 88% · EM ±3.7%Jul 20 — IV 76% · EM ±18.0%Jul 21 — IV 74% · EM ±17.3%Jul 22 — IV 91% · EM ±20.8%Jul 23 — IV 88% · EM ±19.7%Jul 24 — IV 91% · EM ±20.0%Jul 27 — IV 45% · EM ±9.4%Jul 28 — IV 70% · EM ±14.2%Jul 29 — IV 69% · EM ±13.8%Jul 30 — IV 51% · EM ±10.0%Jul 31 — IV 53% · EM ±10.1%Aug 03 — IV 73% · EM ±12.9%Aug 04 — IV 68% · EM ±11.8%Aug 05 — IV 126% · EM ±21.1%Aug 06 — IV 123% · EM ±19.8%Aug 07 — IV 84% · EM ±13.2%Aug 10 — IV 155% · EM ±21.5%Aug 11 — IV 135% · EM ±17.8%Aug 17 — IV 183% · EM ±15.2%Aug 24 — IV 52% · EM ±10.8%Aug 25 — IV 39% · EM ±8.1%Aug 26 — IV 89% · EM ±17.8%Aug 27 — IV 68% · EM ±13.3%Aug 31 — IV 79% · EM ±13.9%Sep 01 — IV 97% · EM ±16.6%Sep 02 — IV 80% · EM ±13.3%Sep 04 — IV 111% · EM ±17.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in